Table of Contents

1 Industry Overview

• 1.1 Chemotherapy Induced Neutropenia Drug Industry
  • 1.1.1 Overview
  • 1.1.2 Development of Chemotherapy Induced Neutropenia Drug
• 1.2 Market Segment
  • 1.2.1 Upstream
  • 1.2.2 Downstream
• 1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

• 2.1 Policy
• 2.2 Economics
• 2.3 Sociology
• 2.4 Technology

3 Chemotherapy Induced Neutropenia Drug Market by Type

• 3.1 By Type
  • 3.1.1 F-627
  • 3.1.2 BBT-018
  • 3.1.3 Filgrastim
  • 3.1.4 GW-003
  • 3.1.5 NLA-101
  • 3.1.6 Others
• 3.2 Market Size
• 3.3 Market Forecast

4 Major Companies List

4.Chemotherapy Induced Neutropenia Drug BeyondSpring Pharmaceuticals Inc (Company Profile, Sales Data etc.)

• 4.2 Biocon Ltd (Company Profile, Sales Data etc.)
• 4.3 Bolder Biotechnology Inc (Company Profile, Sales Data etc.)
• 4.4 Cellerant Therapeutics Inc (Company Profile, Sales Data etc.)
• 4.5 Chong Kun Dang Pharmaceutical Corp (Company Profile, Sales Data etc.)
• 4.6 Cinfa Biotech SL (Company Profile, Sales Data etc.)
• 4.7 Dr. Reddy's Laboratories Ltd (Company Profile, Sales Data etc.)
• 4.8 Gene Techno Science Co Ltd (Company Profile, Sales Data etc.)
• 4.9 Generon (Shanghai) Corp Ltd (Company Profile, Sales Data etc.)
• 4.10 Genexine Inc (Company Profile, Sales Data etc.)
• 4.11 GlycoMimetics Inc (Company Profile, Sales Data etc.)
• 4.12 Hanmi Pharmaceuticals Co Ltd (Company Profile, Sales Data etc.)
• 4.13 Intas Pharmaceuticals Ltd (Company Profile, Sales Data etc.)
• 4.14 Lupin Ltd (Company Profile, Sales Data etc.)
• 4.15 Mycenax Biotech Inc (Company Profile, Sales Data etc.)
• 4.16 Myelo Therapeutics GmbH (Company Profile, Sales Data etc.)
• 4.17 Nohla Therapeutics Inc (Company Profile, Sales Data etc.)
• 4.18 Octapharma AG (Company Profile, Sales Data etc.)
• 4.19 Pangen Biotech Inc. (Company Profile, Sales Data etc.)
• 4.20 Pfenex Inc (Company Profile, Sales Data etc.)
• 4.21 Pfizer Inc (Company Profile, Sales Data etc.)
• 4.22 Reliance Life Sciences Pvt Ltd (Company Profile, Sales Data etc.)
• 4.23 Richter Gedeon Nyrt (Company Profile, Sales Data etc.)
• 4.24 Sandoz International GmbH (Company Profile, Sales Data etc.)
• 4.25 USV Pvt Ltd (Company Profile, Sales Data etc.)

5 Market Competition

• 5.1 Company Competition
• 5.2 Regional Market by Company

6 Demand by End Market

• 6.1 Demand Situation
  • 6.1.1 Demand in Hospital
  • 6.1.2 Demand in Clinic
  • 6.1.3 Demand in Others
• 6.2 Regional Demand Comparison
• 6.3 Demand Forecast

7 Region Operation

• 7.1 Regional Production
• 7.2 Regional Market
• 7.3 by Region
  • 7.3.1 North America
    • 7.3.1.1 Overview
    • 7.3.1.2 by Country (U.S., Canada, Mexico)
  • 7.3.2 Europe
    • 7.3.2.1 Overview
    • 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  • 7.3.3 Asia-Pacific
    • 7.3.3.1 Overview
    • 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  • 7.3.4 South America
    • 7.3.4.1 Overview
    • 7.3.4.2 by Country (Brazil, Argentina etc.)
  • 7.3.5 Middle East & Africa
    • 7.3.5.1 Overview
    • 7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
• 7.4 Regional Import & Export
• 7.5 Regional Forecast

8 Marketing & Price

• 8.1 Price and Margin
  • 8.1.1 Price Trends
  • 8.1.2 Factors of Price Change
  • 8.1.3 Manufacturers Gross Margin Analysis
• 8.2 Marketing Channel

9 Research Conclusion

List of Tables

Table Upstream Segment of Chemotherapy Induced Neutropenia Drug

Table Application Segment of Chemotherapy Induced Neutropenia Drug

Table Global Chemotherapy Induced Neutropenia Drug Market 2013-2024, by Application, in USD Million

Table Major Company List of F-627

Table Major Company List of BBT-018

Table Major Company List of Filgrastim

Table Major Company List of GW-003

Table Major Company List of NLA-101

Table Major Company List of Others

Table Global Chemotherapy Induced Neutropenia Drug Market 2013-2018, by Type, in USD Million

Table Global Chemotherapy Induced Neutropenia Drug Market 2013-2018, by Type, in Volume

Table Global Chemotherapy Induced Neutropenia Drug Market Forecast 2019-2024, by Type, in USD Million

Table Global Chemotherapy Induced Neutropenia Drug Market Forecast 2019-2024, by Type, in Volume

Table BeyondSpring Pharmaceuticals Inc Overview List

Table Chemotherapy Induced Neutropenia Drug Business Operation of BeyondSpring Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Biocon Ltd Overview List

Table Chemotherapy Induced Neutropenia Drug Business Operation of Biocon Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bolder Biotechnology Inc Overview List

Table Chemotherapy Induced Neutropenia Drug Business Operation of Bolder Biotechnology Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Cellerant Therapeutics Inc Overview List

Table Chemotherapy Induced Neutropenia Drug Business Operation of Cellerant Therapeutics Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Chong Kun Dang Pharmaceutical Corp Overview List

Table Chemotherapy Induced Neutropenia Drug Business Operation of Chong Kun Dang Pharmaceutical Corp (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Cinfa Biotech SL Overview List

Table Chemotherapy Induced Neutropenia Drug Business Operation of Cinfa Biotech SL (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Dr. Reddy's Laboratories Ltd Overview List

Table Chemotherapy Induced Neutropenia Drug Business Operation of Dr. Reddy's Laboratories Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Gene Techno Science Co Ltd Overview List

Table Chemotherapy Induced Neutropenia Drug Business Operation of Gene Techno Science Co Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Generon (Shanghai) Corp Ltd Overview List

Table Chemotherapy Induced Neutropenia Drug Business Operation of Generon (Shanghai) Corp Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Genexine Inc Overview List

Table Chemotherapy Induced Neutropenia Drug Business Operation of Genexine Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table GlycoMimetics Inc Overview List

Table Chemotherapy Induced Neutropenia Drug Business Operation of GlycoMimetics Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Hanmi Pharmaceuticals Co Ltd Overview List

Table Chemotherapy Induced Neutropenia Drug Business Operation of Hanmi Pharmaceuticals Co Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Intas Pharmaceuticals Ltd Overview List

Table Chemotherapy Induced Neutropenia Drug Business Operation of Intas Pharmaceuticals Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Lupin Ltd Overview List

Table Chemotherapy Induced Neutropenia Drug Business Operation of Lupin Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Mycenax Biotech Inc Overview List

Table Chemotherapy Induced Neutropenia Drug Business Operation of Mycenax Biotech Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Myelo Therapeutics GmbH Overview List

Table Chemotherapy Induced Neutropenia Drug Business Operation of Myelo Therapeutics GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Nohla Therapeutics Inc Overview List

Table Chemotherapy Induced Neutropenia Drug Business Operation of Nohla Therapeutics Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Octapharma AG Overview List

Table Chemotherapy Induced Neutropenia Drug Business Operation of Octapharma AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Pangen Biotech Inc. Overview List

Table Chemotherapy Induced Neutropenia Drug Business Operation of Pangen Biotech Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Pfenex Inc Overview List

Table Chemotherapy Induced Neutropenia Drug Business Operation of Pfenex Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Pfizer Inc Overview List

Table Chemotherapy Induced Neutropenia Drug Business Operation of Pfizer Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Reliance Life Sciences Pvt Ltd Overview List

Table Chemotherapy Induced Neutropenia Drug Business Operation of Reliance Life Sciences Pvt Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Richter Gedeon Nyrt Overview List

Table Chemotherapy Induced Neutropenia Drug Business Operation of Richter Gedeon Nyrt (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sandoz International GmbH Overview List

Table Chemotherapy Induced Neutropenia Drug Business Operation of Sandoz International GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table USV Pvt Ltd Overview List

Table Chemotherapy Induced Neutropenia Drug Business Operation of USV Pvt Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Chemotherapy Induced Neutropenia Drug Sales Revenue 2013-2018, by Company, in USD Million

Table Global Chemotherapy Induced Neutropenia Drug Sales Revenue Share, by Company, in USD Million

Table Global Chemotherapy Induced Neutropenia Drug Sales Volume 2013-2018, by Company, in Volume

Table Global Chemotherapy Induced Neutropenia Drug Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Chemotherapy Induced Neutropenia Drug Demand Forecast 2019-2024, by Application, in USD Million

Table Chemotherapy Induced Neutropenia Drug Demand Forecast 2019-2024, by Application, in Volume

Table Chemotherapy Induced Neutropenia Drug Production 2013-2018, by Region, in USD Million

Table Chemotherapy Induced Neutropenia Drug Production 2013-2018, by Region, in Volume

Table Global Chemotherapy Induced Neutropenia Drug Market 2013-2018, by Region, in USD Million

Table Global Chemotherapy Induced Neutropenia Drug Market Share 2013-2018, by Region, in USD Million

Table Global Chemotherapy Induced Neutropenia Drug Market 2013-2018, by Region, in Volume

Table Global Chemotherapy Induced Neutropenia Drug Market Share 2013-2018, by Region, in Volume

Table North America Chemotherapy Induced Neutropenia Drug Market Size 2013-2018, by Country, in USD Million

Table North America Chemotherapy Induced Neutropenia Drug Market Size 2013-2018, by Country, in Volume

Table Europe Chemotherapy Induced Neutropenia Drug Market Size 2013-2018, by Country, in USD Million

Table Europe Chemotherapy Induced Neutropenia Drug Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Chemotherapy Induced Neutropenia Drug Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Chemotherapy Induced Neutropenia Drug Market Size 2013-2018, by Country, in Volume

Table South America Chemotherapy Induced Neutropenia Drug Market Size 2013-2018, by Country, in USD Million

Table South America Chemotherapy Induced Neutropenia Drug Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Chemotherapy Induced Neutropenia Drug Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Chemotherapy Induced Neutropenia Drug Market Size 2013-2018, by Country, in Volume

Table Chemotherapy Induced Neutropenia Drug Market Forecast 2019-2024, by Region, in USD Million

Table Chemotherapy Induced Neutropenia Drug Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

List of Figures

Figure Global Chemotherapy Induced Neutropenia Drug Market Growth 2013-2018, by Type, in USD Million

Figure Global Chemotherapy Induced Neutropenia Drug Market Growth 2013-2018, by Type, in Volume

Figure North America Chemotherapy Induced Neutropenia Drug Market Concentration, in 2018

Figure Europe Chemotherapy Induced Neutropenia Drug Market Market Concentration, in 2018

Figure Asia-Pacific Chemotherapy Induced Neutropenia Drug MMarket Concentration, in 2018

Figure South America Chemotherapy Induced Neutropenia Drug Market Concentration, in 2018

Figure Middle East & Africa Chemotherapy Induced Neutropenia Drug Market Concentration, in 2018

Figure Chemotherapy Induced Neutropenia Drug Demand in Hospital, 2013-2018, in USD Million

Figure Chemotherapy Induced Neutropenia Drug Demand in Hospital, 2013-2018, in Volume

Figure Chemotherapy Induced Neutropenia Drug Demand in Clinic, 2013-2018, in USD Million

Figure Chemotherapy Induced Neutropenia Drug Demand in Clinic, 2013-2018, in Volume

Figure Chemotherapy Induced Neutropenia Drug Demand in Others, 2013-2018, in USD Million

Figure Chemotherapy Induced Neutropenia Drug Demand in Others, 2013-2018, in Volume

Figure North America Chemotherapy Induced Neutropenia Drug Market Size and Growth 2013-2018, in USD Million

Figure North America Chemotherapy Induced Neutropenia Drug Market Size and Growth 2013-2018, in Volume

Figure Europe Chemotherapy Induced Neutropenia Drug Market Size and Growth 2013-2018, in USD Million

Figure Europe Chemotherapy Induced Neutropenia Drug Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Chemotherapy Induced Neutropenia Drug Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Chemotherapy Induced Neutropenia Drug Market Size and Growth 2013-2018, in Volume

Figure South America Chemotherapy Induced Neutropenia Drug Market Size and Growth 2013-2018, in USD Million

Figure South America Chemotherapy Induced Neutropenia Drug Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Chemotherapy Induced Neutropenia Drug Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Chemotherapy Induced Neutropenia Drug Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview

Snapshot
The global Chemotherapy Induced Neutropenia Drug market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Chemotherapy Induced Neutropenia Drug by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
F-627
BBT-018
Filgrastim
GW-003
NLA-101
Others
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
BeyondSpring Pharmaceuticals Inc
Biocon Ltd
Bolder Biotechnology Inc
Cellerant Therapeutics Inc
Chong Kun Dang Pharmaceutical Corp
Cinfa Biotech SL
Dr. Reddy's Laboratories Ltd
Gene Techno Science Co Ltd
Generon (Shanghai) Corp Ltd
Genexine Inc
GlycoMimetics Inc
Hanmi Pharmaceuticals Co Ltd
Intas Pharmaceuticals Ltd
Lupin Ltd
Mycenax Biotech Inc
Myelo Therapeutics GmbH
Nohla Therapeutics Inc
Octapharma AG
Pangen Biotech Inc.
Pfenex Inc
Pfizer Inc
Reliance Life Sciences Pvt Ltd
Richter Gedeon Nyrt
Sandoz International GmbH
USV Pvt Ltd
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospital
Clinic
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)